James Huang, Director at CASI Pharmaceuticals, Inc. (CASI), bought 74,735 shares at $3.89 ($304K) on 2022-09-06, disclosed to the SEC on 2022-09-08.
Open-market purchase of $304k CASI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.89 | 19,162 | $75K | 24.5% |
| 2 | $3.89 | 19,162 | $75K | 24.5% |
| 3 | $4.00 | 3,111 | $12K | 4.1% |
| 4 | $4.28 | 33,300 | $143K | 46.9% |
| Total | $4.07 avg | 74,735 | $304K | 100% |
| Filing → |
| ATRA | SELL | 2026-01-14 | $489K | — | Filing → |
| ATRA | BUY | 2025-07-21 | $373K | — | Filing → |
| CASI | BUY | 2022-09-02 | $233K | — | Filing → |